ICE Bioscience is excited to announce our participation in the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2024), taking place from November 8 to 10, 2024, at the George R. Brown Convention Center in Houston, TX. Join us at Booth #1030 to explore our latest advancements in immunotherapy and drug discovery.

We will be presenting four key posters from Friday, November 8 to Saturday, November 9, showcasing our cutting-edge screening platforms:

1.    The cGAS-STING Screening Cascade Facilitates New Drug Discovery

2.    JAK-STAT Platform for Immune-Related Drug Discovery

3.    NLRP3-Based Platform for Immune-Related Drug Discovery

4.    A Neuroinflammation Screening Cascade to Facilitate Novel Drug Discovery

Our experts will be on hand at Booth #1030 to engage with attendees, discuss potential collaborations, and share insights on how our platforms can accelerate the development of novel immunotherapies.